Low genetic diversity and functional constraint in loci encoding Plasmodium vivax P12 and P38 proteins in the Colombian population

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Forero Rodríguez, Johanna ^a,b   Garzón Ospina, Diego ^a,c   Patarroyo, Manuel A ^a,c  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

6 Cys; Anti malarial vaccine; Functional constraint; Genetic diversity; Plasmodium vivax; pv12; pv38; s48 45 domain

Indexed keywords

MALARIA VACCINE; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTEIN P12; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; COLOMBIA; EFFECTIVE POPULATION SIZE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MOLECULAR EVOLUTION; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, PROTOZOAN; COLOMBIA; DNA, PROTOZOAN; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84896728102     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-58     Document Type: Article

References (88)

1. Progress in malaria research: the case for phylogenetics. Rich SM, Ayala FJ, Adv Parasitol 2003 54 255 280 14711087 (Pubitemid 37542913)
2. Plasmodium knowlesi: the fifth human malaria parasite. White NJ, Clin Infect Dis 2008 46 172 173 10.1086/524889 18171246 (Pubitemid 351269153)
3. WHO, World Malaria Report 2012 Geneva: World Health Organization 2012 http://www.who.int/malaria/publications/world-malaria-report-2012/ wmr2012-no-profiles.pdf
4. Vivax malaria: neglected and not benign. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, Am J Trop Med Hyg 2007 77 79 87 18165478
5. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Müeller I, Baird JK, Hay SI, PLoS Negl Trop Dis 2012 6 1814 10.1371/journal.pntd.0001814 22970336
6. Drug resistance in malaria. http://www.who.int/csr/resources/ publications/drugresist/malaria.pdf
7. Identification of a novel class of insect glutathione S-transferases involved in resistance to DDT in the malaria vector Anopheles gambiae. Ranson H, Rossiter L, Ortelli F, Jensen B, Wang X, Roth CW, Collins FH, Hemingway J, Biochem J 2001 359 295 304 10.1042/0264-6021:3590295 11583575 (Pubitemid 32999773)
8. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects. Carvalho LJ, Daniel-Ribeiro CT, Goto H, Scand J Immunol 2002 56 327 343 10.1046/j.1365-3083.2002.01160.x 12234254
9. Malaria vaccine development. Jones TR, Hoffman SL, Clin Microbiol Rev 1994 7 303 310 7923051 (Pubitemid 24216123)
10. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA, Parasitology 2006 133 661 672 10.1017/S0031182006001168 16978450 (Pubitemid 44763962)
11. Plasmodium vivax Duffy binding protein: a modular evolutionary proposal. Martinez P, Suarez CF, Cardenas PP, Patarroyo MA, Parasitology 2004 128 353 366 10.1017/S0031182003004773 15151140 (Pubitemid 38621694)
12. Intragenic recombination in the 3′ portion of the merozoite surface protein 1 gene of Plasmodium vivax. Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K, Mol Biochem Parasitol 2000 109 111 119 10.1016/S0166-6851(00)00238-3 10960170 (Pubitemid 30665408)
13. Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins. Putaporntip C, Udomsangpetch R, Pattanawong U, Cui L, Jongwutiwes S, Gene 2010 456 24 35 10.1016/j.gene.2010.02. 007 20178839
14. Genetic diversity and selection in three Plasmodium vivax merozoite surface protein 7 (Pvmsp-7) genes in a Colombian population. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo MA, PLoS One 2012 7 45962 10.1371/journal.pone.0045962 23049905
15. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, Walker J, Saul A, Mol Biochem Parasitol 2000 108 53 66 10.1016/S0166-6851(00)00204-8 10802318 (Pubitemid 30236315)
16. Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3alpha from the malaria parasite Plasmodium vivax in Thailand. Mascorro CN, Zhao K, Khuntirat B, Sattabongkot J, Yan G, Escalante AA, Cui L, Parasitology 2005 131 25 35 10.1017/S0031182005007547 16038393 (Pubitemid 41008806)
17. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Escalante AA, Lal AA, Ayala FJ, Genetics 1998 149 189 202 9584096
18. Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax. Chenet SM, Tapia LL, Escalante AA, Durand S, Lucas C, Bacon DJ, Malar J 2012 11 68 10.1186/1475-2875-11-68 22417572
19. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. Takala SL, Plowe CV, Parasite Immunol 2009 31 560 573 10.1111/j.1365-3024.2009.01138.x 19691559
20. Asexual blood-stage malaria vaccine development: facing the challenges. Genton B, Reed ZH, Curr Opin Infect Dis 2007 20 467 475 10.1097/QCO. 0b013e3282dd7a29 17762779 (Pubitemid 47359642)
21. Strain-specific humoral response to a polymorphic malaria vaccine. Fluck C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I, Infect Immun 2004 72 6300 6305 10.1128/IAI.72.11.6300-6305.2004 15501757 (Pubitemid 39425408)
22. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J, Blackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV, J Infect Dis 2013 207 511 519 10.1093/infdis/jis709 23204168
23. How protozoan parasites evade the immune response. Zambrano-Villa S, Rosales-Borjas D, Carrero JC, Ortiz-Ortiz L, Trends Parasitol 2002 18 272 278 10.1016/S1471-4922(02)02289-4 12036742 (Pubitemid 34569238)
24. Progress and challenges for malaria vaccines. Richie TL, Saul A, Nature 2002 415 694 701 10.1038/415694a 11832958 (Pubitemid 34136403)
25. Kimura M, The neutral theory of molecular evolution. Cambridge Cambridgeshire New York: Cambridge University Press 1983
26. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. O'Donnell RA, De Koning-Ward TF, Burt RA, Bockarie M, Reeder JC, Cowman AF, Crabb BS, J Exp Med 2001 193 1403 1412 10.1084/jem.193.12.1403 11413195 (Pubitemid 32565969)
27. Detergent-resistant erythrocyte membrane rafts are modified by a Plasmodium falciparum infection. Nagao E, Seydel KB, Dvorak JA, Exp Parasitol 2002 102 57 59 10.1016/S0014-4894(02)00143-1 12615167 (Pubitemid 36279584)
28. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, Carucci DJ, McConville MJ, Schofield L, Hodder AN, Yates JR 3rd, Crabb BS, J Biol Chem 2005 280 40169 40176 10.1074/jbc.M509631200 16203726 (Pubitemid 41779153)
29. Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells. Arevalo-Pinzon G, Curtidor H, Vanegas M, Vizcaino C, Patarroyo MA, Patarroyo ME, Peptides 2010 31 1987 1994 10.1016/j.peptides.2010.07.009 20654670
30. Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Garcia J, Curtidor H, Pinzon CG, Vanegas M, Moreno A, Patarroyo ME, Vaccine 2009 27 3953 3962 10.1016/j.vaccine.2009.04.039 19389446
31. Identifying merozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum protein family members specifically binding to human erythrocytes suggests a new malarial parasite-redundant survival mechanism. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno A, Patarroyo ME, J Med Chem 2007 50 5665 5675 10.1021/jm070773z 17944453 (Pubitemid 350106021)
32. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H, Segura C, Trujillo E, Patarroyo ME, Parasite Immunol 1996 18 515 526 10.1046/j.1365-3024.1996.d01-15.x 9226689 (Pubitemid 26342890)
33. Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo ME, Chem Rev 2008 108 3656 3705 10.1021/cr068407v 18710292
34. Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P. vivax in Aotus monkeys. Barrero CA, Delgado G, Sierra AY, Silva Y, Parra-Lopez C, Patarroyo MA, Vaccine 2005 23 4048 4053 10.1016/j.vaccine.2005.02.012 15893858 (Pubitemid 40800665)
35. The future for blood-stage vaccines against malaria. Richards JS, Beeson JG, Immunol Cell Biol 2009 87 377 390 10.1038/icb.2009.27 19417768
36. Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility. Van Dijk MR, Van Schaijk BC, Khan SM, Van Dooren MW, Ramesar J, Kaczanowski S, Van Gemert GJ, Kroeze H, Stunnenberg HG, Eling WM, et al. PLoS Pathog 2010 6 1000853 10.1371/journal.ppat.1000853 20386715
37. Pfs230: from malaria transmission-blocking vaccine candidate toward function. Williamson KC, Parasite Immunol 2003 25 351 359 10.1046/j.1365-3024. 2003.00643.x 14521577 (Pubitemid 38019278)
38. Characterisation of the Plasmodium vivax Pv38 antigen. Mongui A, Angel DI, Guzman C, Vanegas M, Patarroyo MA, Biochem Biophys Res Commun 2008 376 326 330 10.1016/j.bbrc.2008.08.163 18789893
39. The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts. Moreno-Perez DA, Areiza-Rojas R, Florez-Buitrago X, Silva Y, Patarroyo ME, Patarroyo MA, Protist 2013 164 37 48 10.1016/j.protis.2012.03.001 22554829
40. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET, J Proteome Res 2010 9 6479 6489 10.1021/pr100705g 20949973
41. Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Prajapati SK, Joshi H, Shalini S, Patarroyo MA, Suwanarusk R, Kumar A, Sharma SK, Eapen A, Dev V, Bhatt RM, Valecha N, Nosten F, Rizvi MA, Dash AP, Malar J 2011 10 374 10.1186/1475-2875- 10-374 22182774
42. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, White NJ, Snounou G, Malar J 2005 4 20 10.1186/1475-2875-4-20 15854233 (Pubitemid 40918738)
43. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young S, Zeng Q, Chapman SB, Dash AP, Anvikar AR, Sutton PL, Birren BW, Escalante AA, Barnwell JW, Carlton JM, Nat Genet 2012 44 1046 1050 10.1038/ng.2373 22863733
44. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J, Angiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RM, Crabb BS, Del Portillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, Gueye AH, Guo X, Kang'a S, Kooij TW, Korsinczky M, Meyer EV, Nene V, Paulsen I, White O, Ralph SA, Ren Q, Sargeant TJ, et al. Nature 2008 455 757 763 10.1038/nature07327 18843361
45. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Edgar RC, Nucleic Acids Res 2004 32 1792 1797 10.1093/nar/gkh340 15034147 (Pubitemid 38832724)
46. PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Suyama M, Torrents D, Bork P, Nucleic Acids Res 2006 34 609 W612 10.1093/nar/gkl315 16845082 (Pubitemid 44529842)
47. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Librado P, Rozas J, Bioinformatics 2009 25 1451 1452 10.1093/bioinformatics/ btp187 19346325
48. Neutrality tests based on the distribution of haplotypes under an infinite-site model. Depaulis F, Veuille M, Mol Biol Evol 1998 15 1788 1790 10.1093/oxfordjournals.molbev.a025905 9917213 (Pubitemid 28551002)
49. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Tajima F, Genetics 1989 123 585 595 2513255 (Pubitemid 19274682)
50. Statistical tests of neutrality of mutations. Fu YX, Li WH, Genetics 1993 133 693 709 8454210
51. Hitchhiking under positive Darwinian selection. Fay JC, Wu CI, Genetics 2000 155 1405 1413 10880498 (Pubitemid 30463447)
52. Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Fu YX, Genetics 1997 147 915 925 9335623
53. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Zhang J, Rosenberg HF, Nei M, Proc Natl Acad Sci U S A 1998 95 3708 3713 10.1073/pnas.95.7.3708 9520431 (Pubitemid 28173193)
54. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S, Mol Biol Evol 2011 28 2731 2739 10.1093/molbev/msr121 21546353
55. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Kosakovsky Pond SL, Frost SD, Mol Biol Evol 2005 22 1208 1222 10.1093/molbev/msi105 15703242 (Pubitemid 40577758)
56. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ, PLoS Comput Biol 2006 2 62 10.1371/journal.pcbi.0020062 16789820 (Pubitemid 43990669)
57. Detecting individual sites subject to episodic diversifying selection. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL, PLoS Genet 2012 8 1002764 10.1371/journal.pgen.1002764 22807683
58. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, Scheffler K, Mol Biol Evol 2013 30 1196 1205 10.1093/molbev/mst030 23420840
59. Evolution of protein molecules. Jukes TH, Cantor CR, Mammalian Protein Metabolism New York: Academic Press, Munro HN, 1969
60. Adaptive protein evolution at the Adh locus in Drosophila. McDonald JH, Kreitman M, Nature 1991 351 652 654 10.1038/351652a0 1904993 (Pubitemid 21896661)
61. Standard and generalized McDonald-Kreitman test: a website to detect selection by comparing different classes of DNA sites. Egea R, Casillas S, Barbadilla A, Nucleic Acids Res 2008 36 157 W162 10.1093/nar/gkn337 18515345
62. A test of neutrality based on interlocus associations. Kelly JK, Genetics 1997 146 1197 1206 9215920 (Pubitemid 27291000)
63. DNA variation at the rp49 gene region of Drosophila simulans: evolutionary inferences from an unusual haplotype structure. Rozas J, Gullaud M, Blandin G, Aguade M, Genetics 2001 158 1147 1155 11454763 (Pubitemid 32667100)
64. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Hudson RR, Kaplan NL, Genetics 1985 111 147 164 4029609 (Pubitemid 16248827)
65. Automated phylogenetic detection of recombination using a genetic algorithm. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD, Mol Biol Evol 2006 23 1891 1901 10.1093/molbev/msl051 16818476 (Pubitemid 44412875)
66. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL, Bioinformatics 2010 26 2455 2457 10.1093/bioinformatics/btq429 20671151
67. The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, Herrera S, Kim JY, Menard D, Póvoa MM, Villegas L, Mulyanto, Snounou G, Cui L, Zeyrek FY, Escalante AA, Mol Biol Evol 2013 30 2050 2064 10.1093/molbev/mst104 23733143
68. Prospective identification of malaria parasite genes under balancing selection. Tetteh KK, Stewart LB, Ochola LI, Amambua-Ngwa A, Thomas AW, Marsh K, Weedall GD, Conway DJ, PLoS One 2009 4 5568 10.1371/journal.pone.0005568 19440377
69. Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41. Tonkin ML, Arredondo SA, Loveless BC, Serpa JJ, Makepeace KA, Sundar N, Petrotchenko EV, Miller LH, Grigg ME, Boulanger MJ, J Biol Chem 2013 288 12805 12817 10.1074/jbc.M113.455667 23511632
70. Evidence for negative selection on the gene encoding rhoptry-associated protein 1 (RAP-1) in Plasmodium spp. Pacheco MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE, Escalante AA, Infect Genet Evol 2010 10 655 661 10.1016/j.meegid.2010.03.013 20363375
71. Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW, Escalante AA, Infect Genet Evol 2012 12 978 986 10.1016/j.meegid.2012.02.009 22414917
72. Structure of the Plasmodium 6-cysteine s48/45 domain. Arredondo SA, Cai M, Takayama Y, MacDonald NJ, Anderson DE, Aravind L, Clore GM, Miller LH, Proc Natl Acad Sci U S A 2012 109 6692 6697 10.1073/pnas.1204363109 22493233
73. Population genetic analysis of the Plasmodium falciparum 6-cys protein Pf38 in Papua New Guinea reveals domain-specific balancing selection. Reeder JC, Wapling J, Mueller I, Siba PM, Barry AE, Malar J 2011 10 126 10.1186/1475-2875-10-126 21569602
74. The influence of demography and weak selection on the McDonald-Kreitman test: an empirical study in Drosophila. Parsch J, Zhang Z, Baines JF, Mol Biol Evol 2009 26 691 698 19126864
75. High sequence diversity and evidence of balancing selection in the Pvmsp3alpha gene of Plasmodium vivax in the Venezuelan Amazon. Ord R, Polley S, Tami A, Sutherland CJ, Mol Biochem Parasitol 2005 144 86 93 10.1016/j. molbiopara.2005.08.005 16159677 (Pubitemid 41393373)
76. Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates. Kang JM, Ju HL, Kang YM, Lee DH, Moon SU, Sohn WM, Park JW, Kim TS, Na BK, Malar J 2012 11 206 10.1186/1475-2875-11-206 22709605
77. Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1 (AMA-1) of Iranian Plasmodium vivax wild isolates. Zakeri S, Sadeghi H, Mehrizi AA, Djadid ND, Acta Trop 2013 126 269 279 10.1016/j.actatropica.2013.02.017 23467011
78. Genetic polymorphism and natural selection of Duffy binding protein of Plasmodium vivax Myanmar isolates. Ju HL, Kang JM, Moon SU, Kim JY, Lee HW, Lin K, Sohn WM, Lee JS, Kim TS, Na BK, Malar J 2012 11 60 10.1186/1475-2875-11-60 22380592
79. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Garzon-Ospina D, Romero-Murillo L, Tobon LF, Patarroyo MA, Infect Genet Evol 2011 11 528 531 10.1016/j.meegid.2010.12.002 21182986
80. Limited genetic polymorphism of the Plasmodium vivax low molecular weight rhoptry protein complex in the Colombian population. Garzon-Ospina D, Romero-Murillo L, Patarroyo MA, Infect Genet Evol 2010 10 261 267 10.1016/j.meegid.2009.12.004 20026428
81. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA, Infect Genet Evol 2005 5 354 361 10.1016/j.meegid.2004.12.001 16168942 (Pubitemid 41350045)
82. Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, Sattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T, Vaccine 2011 29 4308 4315 10.1016/j.vaccine.2011.04.028 21514344
83. Vaccines against Plasmodium vivax: a research challenge. Patarroyo MA, Calderon D, Moreno-Perez DA, Expert Rev Vaccines 2012 11 1249 1260 10.1586/erv.12.91 23176656
84. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection. Giraldo MA, Arevalo-Pinzon G, Rojas-Caraballo J, Mongui A, Rodriguez R, Patarroyo MA, Vaccine 2009 28 7 13 10.1016/j.vaccine.2009.09.046 19782110
85. Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: a potential vaccine candidate. Rojas-Caraballo J, Mongui A, Giraldo MA, Delgado G, Granados D, Millan-Cortes D, Martinez P, Rodriguez R, Patarroyo MA, Vaccine 2009 27 2870 2876 10.1016/j.vaccine.2009.02.083 19428897
86. Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. Carter R, Coulson A, Bhatti S, Taylor BJ, Elliott JF, Mol Biochem Parasitol 1995 71 203 210 10.1016/0166-6851(94)00054-Q 7477102
87. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T, Vaccine 2012 30 1807 1812 10.1016/j.vaccine.2012.01.003 22245309
88. Plant-based production of recombinant Plasmodium surface protein pf38 and evaluation of its potential as a vaccine candidate. Feller T, Thom P, Koch N, Spiegel H, Addai-Mensah O, Fischer R, Reimann A, Pradel G, Fendel R, Schillberg S, Scheuermayer M, Schinkel H, PLoS One 2013 8 79920 10.1371/journal.pone. 0079920 24278216